Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Cannabidiol in Pain: NCT07549256 Clinical Landscape Report 2026
9 min read
Cannabidiol in Pain: NCT07549256 Clinical Landscape Report 2026
15 October 2026
NCT07549256 clinical landscape for Pain: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tenofovir Alafenamide Fumarate in Hepatitis B, Chronic: NCT07553767 Clinical Landscape Report 2026
9 min read
Tenofovir Alafenamide Fumarate in Hepatitis B, Chronic: NCT07553767 Clinical Landscape Report 2026
15 October 2026
NCT07553767 clinical landscape for Hepatitis B, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
NRT6008 in Pancreatic carcinoma non-resectable: NCT07555587 Clinical Landscape Report 2026
9 min read
NRT6008 in Pancreatic carcinoma non-resectable: NCT07555587 Clinical Landscape Report 2026
15 October 2026
NCT07555587 clinical landscape for Pancreatic carcinoma non-resectable: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →
Sintilimab in Hepatitis B Virus-Related Hepatocellular Carcinoma: NCT07557251 Clinical Landscape Report 2026
9 min read
Sintilimab in Hepatitis B Virus-Related Hepatocellular Carcinoma: NCT07557251 Clinical Landscape Report 2026
15 October 2026
NCT07557251 clinical landscape for Hepatitis B Virus-Related Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and deve…
Read →
HRS-1780 in Chronic Kidney Diseases: NCT07557407 Clinical Landscape Report 2026
9 min read
HRS-1780 in Chronic Kidney Diseases: NCT07557407 Clinical Landscape Report 2026
15 October 2026
NCT07557407 clinical landscape for Chronic Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Apixaban in Arteriovenous Fistula: NCT07559942 Clinical Landscape Report 2026
9 min read
Apixaban in Arteriovenous Fistula: NCT07559942 Clinical Landscape Report 2026
15 October 2026
NCT07559942 clinical landscape for Arteriovenous Fistula: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
INCB123667 in Kidney Failure, Chronic: NCT07559396 Clinical Landscape Report 2026
9 min read
INCB123667 in Kidney Failure, Chronic: NCT07559396 Clinical Landscape Report 2026
15 October 2026
NCT07559396 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Poterepatide in Renal Insufficiency: NCT07559240 Clinical Landscape Report 2026
9 min read
Poterepatide in Renal Insufficiency: NCT07559240 Clinical Landscape Report 2026
15 October 2026
NCT07559240 clinical landscape for Renal Insufficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Hydrocortisone Sodium Succinate in Bartter Syndrome: NCT07558811 Clinical Landscape Report 2026
9 min read
Hydrocortisone Sodium Succinate in Bartter Syndrome: NCT07558811 Clinical Landscape Report 2026
15 October 2026
NCT07558811 clinical landscape for Bartter Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
TEV-56278 in Locally Advanced Malignant Solid Neoplasm: NCT07558200 Clinical Landscape Report 2026
9 min read
TEV-56278 in Locally Advanced Malignant Solid Neoplasm: NCT07558200 Clinical Landscape Report 2026
15 October 2026
NCT07558200 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
Read →
Fosfomycin Calcium Hydrate in Pregnancy Complications, Infectious: NCT07557901 Clinical Landscape Report 2026
9 min read
Fosfomycin Calcium Hydrate in Pregnancy Complications, Infectious: NCT07557901 Clinical Landscape Report 2026
15 October 2026
NCT07557901 clinical landscape for Pregnancy Complications, Infectious: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →
TRC003 in PSMA-Positive Castration-Resistant Prostatic Cancer: NCT07567521 Clinical Landscape Report 2026
9 min read
TRC003 in PSMA-Positive Castration-Resistant Prostatic Cancer: NCT07567521 Clinical Landscape Report 2026
15 October 2026
NCT07567521 clinical landscape for PSMA-Positive Castration-Resistant Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and dev…
Read →